Wang, Y. A., Macaldowie, A., Hayward, I., Chambers, G. M., & Sullivan, E. A. (2011). Assisted Reproductive Technology in Australia and New Zealand 2009. AIHW National Perinatal Epidemiology and Statistics Unit.
Wang YA, Macaldowie A, Hayward I, Chambers GM, Sullivan EA. Assisted Reproductive Technology in Australia and New Zealand 2009. AIHW National Perinatal Epidemiology and Statistics Unit; 2011.
Wang, Y. A., et al. Assisted Reproductive Technology in Australia and New Zealand 2009. AIHW National Perinatal Epidemiology and Statistics Unit, 2011.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.
RRM Academy Synopsis
ANZARD data show 17.2% of 2009 ART cycles ended in a live delivery
17.2% of Australian and New Zealand ART cycles ended in a live delivery in 2009, the national registry report finds, among 70,541 cycles from 37 fertility centers. Per fresh cycle with a woman's own eggs, live delivery fell from 26.8% at ages 30–34 to 0.5% at age 45 or older.
Key Findings
Live delivery per initiated fresh cycle with a woman's own eggs was 26.8% at ages 30–34 and 0.5% at 45 or older; in thaw cycles (frozen embryos), 20.1% and 2.4%.
Among 13,282 babies born after embryo transfer, 17.6% were preterm, compared with 8.2% of babies born in Australia in 2008; preterm singletons were 9.9% against 6.6%.
Among babies born after embryo transfer, the perinatal mortality rate was 15.3 deaths per 1,000 births, against 10.2 per 1,000 births in Australia in 2008.
Multiple deliveries fell from 14.1% in 2005 to 8.2% in 2009 as single embryo transfer rose from 48.3% to 69.7% of embryo transfer cycles.
The registry recorded 70,541 ART cycles in 2009, a 13.9% increase on 2008; 22.6% resulted in a clinical pregnancy and 17.2% in a live delivery.
Interpretation
The Australian and New Zealand Assisted Reproduction Database (ANZARD) compiles data from all 37 fertility centers. The figures are counts and rates for ART, with no untreated comparison group. Cause of infertility is recorded in broad categories diagnosed by each clinician, and definitions may vary among centers. The live delivery and clinical pregnancy rates quoted here are per initiated cycle. Several clinics could not supply the linkage key for the new woman-based collection, and the per-woman chapter leaves out 4,375 of 67,229 autologous cycles for lack of data. The report advises caution with the perinatal mortality figures because of small numbers and self-reported birth outcomes.
RRM Context
Restorative reproductive medicine evaluates both partners, finds the conditions behind infertility, and treats them. A registry of ART cycles counts treatments and records how the babies fared. Cause-based care follows pregnancy per couple over time, a different measure of outcome.
Our editorial summary of this paper, not the article's abstract.
Key figures
Treatment activity, 2009
Measure
Value
Source
Total ART treatment cycles in Australia and New Zealand, 2009
70,541
Summary
Share of ART cycles performed at Australian fertility centres, 2009
92.4%
Summary
Share of ART cycles performed at New Zealand fertility centres, 2009
7.6%
Summary
Autologous ART cycles, 2009
67,229
Report text
Fresh cycles among autologous ART cycles, 2009
43,352 (64.5%)
Report text
Patient profile, autologous cycles 2009
Measure
Value
Source
Autologous fresh cycles undertaken in women aged 40 or older, 2009
26.8%
Summary (age and parity)
Average age of women undergoing autologous ART treatment, 2009
35.8 years
Summary (age and parity)
Pregnancy and birth outcomes, 2009
Measure
Value
Source
Clinical pregnancy rate per ART treatment cycle, 2009
22.6%
Summary
Live delivery rate per ART treatment cycle, 2009
17.2%
Summary
Babies born, 2009
Measure
Value
Source
Live deliveries from ART treatment, 2009
12,127
Summary
Liveborn babies from ART treatment, 2009
13,114
Summary
Singleton babies born at term with normal birthweight, 2009
9,732
Summary
Embryo transfer practice, 2009
Measure
Value
Source
Single embryo transfer (SET) share of autologous fresh embryo transfer cycles, 2009
65.2%
Table 11
Double embryo transfer (DET) share of autologous fresh embryo transfer cycles, 2009
33.8%
Table 11
Live delivery rate for single embryo transfer (SET), autologous fresh cycles, 2009
24.6%
Table 11
Live delivery rate for double embryo transfer (DET), autologous fresh cycles, 2009
20.3%
Table 11
Outcomes by maternal age, autologous fresh cycles 2009
Measure
Value
Source
Live delivery rate per initiated cycle, women aged 30-34, 2009
26.8%
Summary (age and outcomes)
Live delivery rate per initiated cycle, women aged over 44, 2009
less than 1%
Summary (age and outcomes)
Live delivery rate per embryo transfer cycle, youngest maternal age band, 2009
34.0
Report text
Live delivery rate per embryo transfer cycle, second-youngest maternal age band, 2009
32.5
Report text
Live delivery rate per embryo transfer cycle, middle maternal age band, 2009
22.5
Report text
Live delivery rate per embryo transfer cycle, second-oldest maternal age band, 2009
9.4
Report text
Live delivery rate per embryo transfer cycle, oldest maternal age band, 2009
0.8
Report text
Live delivery rate per embryo transfer cycle, all maternal age bands combined (overall average), 2009
23.0
Report text
One-year trend, 2008 to 2009
Measure
Value
Source
Change in total ART treatment cycles, 2008 to 2009
13.9%
Summary
Five-year trend, 2005 to 2009
Measure
Value
Source
Change in total ART treatment cycles, 2005 to 2009
48.0%
Summary
Multiple birth delivery rate for ART, 2005 and 2009
14.1% to 8.2%
Summary (multiple births)
Share of cycles that were single embryo transfer, 2005 and 2009
48.3% to 69.7%
Summary (multiple births)
Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.